Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2022 07:01 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics announces retirement of chief financial officer and succession plan

- Andrew J. Oakley to retire in March 2022 - Dr. Lucinda Crabtree to succeed him as chief financial officer LONDON, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a...
August 28, 2019 16:05 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Participate in Upcoming Investor Conferences in September

LONDON, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...
August 08, 2019 07:49 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress

LONDON, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...